National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Cited as:85 FR 73062
Court:National Institutes Of Health
Publication Date:16 Nov 2020
Record Number:2020-25185
73062
Federal Register / Vol. 85, No. 221 / Monday, November 16, 2020 / Notices
minutes per person to ensure time is
allotted for all those wishing to speak.
Individuals are also welcome to submit
written comments in advance. Written
comments should not exceed three
pages in length. Individuals submitting
comments should email their written
comments or their request to provide a
comment during the meeting to nvac@
hhs.gov at least five business days prior
to the meeting.
Dated: October 27, 2020.
Ann Aikin,
Acting Designated Federal Official, Office of
the Assistant Secretary for Health.
[FR Doc. 2020–25243 Filed 11–13–20; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Microbiology,
Infectious Diseases and AIDS Initial Review
Group; Acquired Immunodeficiency
Syndrome Research Review Committee
Acquired Immunodeficiency Syndrome
Research Review Committee (AIDS).
Date: December 9–10, 2020.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G21,
Rockville, MD 20892 (Telephone Conference
Call).
Contact Person: Robert C. Unfer, PhD.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G21, Rockville, MD
20852, (240) 669–5035, robert.unfer@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 9, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–25185 Filed 11–13–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Muscular Dystrophy
Coordinating Committee (MDCC).
The meeting will be open to the
public. Individuals who plan to
participate and need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify the Contact Person listed
below in advance of the meeting.
Name of Committee: Muscular Dystrophy
Coordinating Committee.
Date: December 16, 2020.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: The purpose of this meeting is to
bring together committee members,
representing government agencies, patient
advocacy groups, other voluntary health
organizations, and patients and their families
to update one another on progress relevant to
the Action Plan for the Muscular Dystrophies
and to coordinate activities and discuss gaps
and opportunities leading to better
understanding of the muscular dystrophies,
advances in treatments, and improvements in
patients’ and their families’ lives. The agenda
for this meeting is available on the MDCC
website: https://www.mdcc.nih.gov/
Meetings_Events/december-16-2020.
Registration: To register, please go to:
https://roseliassociates.zoomgov.com/
webinar/register/WN_ztgxOE-
mQPKtTSwCXWyk1w.
Webcast Live: https://videocast.nih.gov/.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive Blvd.,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Glen Nuckolls, Ph.D.,
Program Director, National Institute of
Neurological, Disorders and Stroke (NINDS),
NIH, 6001 Executive Blvd., Rm 2203,
Bethesda, MD 20892, 301–496–5876, MDCC@
nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
More information can be found on the
Muscular Dystrophy Coordinating Committee
home page: https://mdcc.nih.gov/.
Dated: November 9, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–25190 Filed 11–13–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIH Support for
Conferences and Scientific Meetings (Parent
R13 Clinical Trial Not Allowed).
Date: December 8–10, 2020.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F43,
Rockville, MD 20892, (Virtual Meeting).
Contact Person: Kelly Y. Poe, Ph.D.,
Deputy Director, Scientific Review Officer,
Scientific Review Program, Division of
Extramural Activities, National Institute of
Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane, Room
3F43, Bethesda, MD 20892–9834, (240) 669–
5036, poeky@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 9, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–25187 Filed 11–13–20; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014 20:13 Nov 13, 2020 Jkt 253001 PO 00000 Frm 00046 Fmt 4703 Sfmt 9990 E:\FR\FM\16NON1.SGM 16NON1
jbell on DSKJLSW7X2PROD with NOTICES